Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Ossium Health, Inc.
M.D. Anderson Cancer Center
City of Hope Medical Center
Beijing GoBroad Hospital
Beijing GoBroad Hospital
Columbia University
Emory University
National Institutes of Health Clinical Center (CC)
Myeloid Therapeutics
Peking Union Medical College Hospital
Columbia University
Atara Biotherapeutics
St. Olavs Hospital
Ludwig Institute for Cancer Research
Columbia University
Memorial Sloan Kettering Cancer Center
Alexion Pharmaceuticals, Inc.
Northwestern University
AbbVie
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Northwestern University
National Cancer Institute (NCI)
Stanford University
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Washington
National Cancer Institute (NCI)
University of Michigan
Samsung Medical Center
Pharmacyclics LLC.
University of Minnesota
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Pfizer